Share statistics

Share statistics (as at 18 November 2009)

Number of Ordinary Shares in issue (undiluted)

67,483,311

Number of Ordinary Shares subject to options

1,755,000

Maximum number of Ordinary Shares in issue (fully diluted)

69,238,311

The effect of the options, if all exercised, would be to increase the issued share capital by 2.53% and raise £672,838 gross for the Company.


Share volumes (as at 31 January 2010)

The daily average number of shares traded since the Company was first listed is:

Daily Average Per
Year Since Listing
  Daily Average Per
Month in 2010
2007 219,000 Jan 130,000    
2008 126,000        
2009 118,000        

Share options (as at 31 December 2009)

The number of ordinary shares subject to options granted under the Share Option Schemes of the Company were:

Grant Exercise period (incl) Exercise Price/share No of share
options granted
Cash to Company
on exercise
7/06 2/08 - 1/13 74.5p 200,000 £149,000
7/07 2/09 - 1/14 56.25p 300,000 £168,750
6/08 2/10 - 1/15 41.75p 290,000 £121,075
7/09 8/11 - 7/16 24.25p 965,000 £234,013
Totals     1,755,000 £672,838

Further details of share options issued before December 2009 can be obtained from the Company's Annual Report 2009 which can be found by following this link.


 

Page last up-dated: 2 March 2010

Page last reviewed: 2 March 2010

Major Shareholders
(as at 18 November 2009)

Institutions holding more than 3% of the share capital of Futura were:

  • Brookwell Ltd 4.79%
  • Gartmore Investment Management 4.42%

Other shareholders holding more than 3% of the share capital of Futura were:

  • RA Lamb 7.36%
  • WT Lamb Investments Limited 6.45%
  • Medinvest Holdings Limited 5.92%
  • Christopher John Crabtree 5.11%
  • P McMahon 3.58%

Shares not in public hands

In the terms of the AIM Rules published in February 2007 and insofar as it is aware, at 18 November 2009, 2.42% of the Company's AIM securities were not in public hands.

There are no restrictions on the transfer of Futura Medical securities.